Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-16-006529
Accepted
2016-12-22 00:15:11
Documents
1
Effectiveness Date
2016-12-21
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-16-006529.txt   1830
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-214889 | Film No.: 162064992
SIC: 2836 Biological Products, (No Diagnostic Substances)